U.S. FDA advisory meetings through March 25
CONTACT: Doreen Kezer, 301-827-1249 The committee will meet to discuss pediatric-focused safety reviews, as mandated by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, for L’Oreal sunscreen ingredient Anthelios 40, DuPont imaging agent Cardiolite , Sanofi-Aventis allergy drug Nasacort AQ , Boehringer Ingelheim HIV …
If you enjoyed this post, make sure you subscribe to my RSS feed!
